Status epilepticus management and mortality risk factors: a retrospective study. 2022

M Hidalgo de la Cruz, and J A Miranda Acuña, and E Luque Buzo, and B Chavarria Cano, and E Esteban de Antonio, and J Prieto Montalvo, and M L Galiano Fragua, and A Massot-Tarrús
Servicio de Neurología, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Electronic address: mila.hidalgo.nrl@gmail.com.

BACKGROUND Status epilepticus (SE) is a neurological emergency with relatively high mortality rates. In this study, we analysed the management of SE and identified mortality risk factors that may be addressed with educational interventions or modifications to hospital protocols. METHODS In this retrospective study, we analysed demographic, treatment, and outcome data from 65 patients (mean age, 59 years [range, 44.5-77]; 53.8% women) who were admitted to our tertiary hospital during an 18-month period and met the 2015 International League Against Epilepsy criteria for SE. RESULTS Thirty patients (46.2%) had history of epilepsy. The most frequent causes of SE were cerebrovascular disease (27.7%) and systemic infection (16.9%). The following deviations were observed in the administration of the antiepileptic drugs: benzodiazepines were used as first option in only 33 (50.8%) patients; the combination of 2 benzodiazepines was recorded in 7 cases (10.8%); and lacosamide was used as an off-label drug in 5 patients (7.7%). Electroencephalography studies were performed in only 26 patients (40%); and only 5 studies (7.7% of patients) were performed within 12 hours of seizure onset. The mortality rate was 21.5%. Acute stroke and cerebrovascular complications were associated with higher mortality rates, while previous history of epilepsy and admission to intensive care were related to better prognosis (P <  .05). CONCLUSIONS To improve SE management and reduce mortality rates, training activities targeting emergency department physicians should be implemented, together with elective intensive care admission for patients with multiple mortality risk factors (eg, absence of history of epilepsy, acute stroke, or cardiovascular complications).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001569 Benzodiazepines A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring. Benzodiazepine,Benzodiazepine Compounds
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D013226 Status Epilepticus A prolonged seizure or seizures repeated frequently enough to prevent recovery between episodes occurring over a period of 20-30 minutes. The most common subtype is generalized tonic-clonic status epilepticus, a potentially fatal condition associated with neuronal injury and respiratory and metabolic dysfunction. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial status epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition (see also EPILEPSIA PARTIALIS CONTINUA). Subclinical status epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of seizure activity. (From N Engl J Med 1998 Apr 2;338(14):970-6; Neurologia 1997 Dec;12 Suppl 6:25-30) Absence Status,Complex Partial Status Epilepticus,Generalized Convulsive Status Epilepticus,Non-Convulsive Status Epilepticus,Petit Mal Status,Simple Partial Status Epilepticus,Grand Mal Status Epilepticus,Status Epilepticus, Complex Partial,Status Epilepticus, Electrographic,Status Epilepticus, Generalized,Status Epilepticus, Generalized Convulsive,Status Epilepticus, Grand Mal,Status Epilepticus, Non-Convulsive,Status Epilepticus, Simple Partial,Status Epilepticus, Subclinical,Electrographic Status Epilepticus,Generalized Status Epilepticus,Non Convulsive Status Epilepticus,Status Epilepticus, Non Convulsive,Status, Absence,Status, Petit Mal,Subclinical Status Epilepticus
D056687 Off-Label Use The practice of prescribing or using a drug or a vaccine outside the scope of the drug's official approved label as designated by a regulatory agency concerning the treatment of a particular disease or condition. Dose-Sparing Drug Use,Fractional Dose Drug Use,Off-Label Prescribing,Reduced-Dose Drug Use,Unlabeled Indication,Dose Sparing Drug Use,Dose-Sparing Drug Uses,Indication, Unlabeled,Off Label Prescribing,Off Label Use,Off-Label Prescribings,Off-Label Uses,Prescribing, Off-Label,Reduced Dose Drug Use,Reduced-Dose Drug Uses,Unlabeled Indications
D020521 Stroke A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810) Apoplexy,Cerebral Stroke,Cerebrovascular Accident,Cerebrovascular Apoplexy,Vascular Accident, Brain,CVA (Cerebrovascular Accident),Cerebrovascular Accident, Acute,Cerebrovascular Stroke,Stroke, Acute,Acute Cerebrovascular Accident,Acute Cerebrovascular Accidents,Acute Stroke,Acute Strokes,Apoplexy, Cerebrovascular,Brain Vascular Accident,Brain Vascular Accidents,CVAs (Cerebrovascular Accident),Cerebral Strokes,Cerebrovascular Accidents,Cerebrovascular Accidents, Acute,Cerebrovascular Strokes,Stroke, Cerebral,Stroke, Cerebrovascular,Strokes,Strokes, Acute,Strokes, Cerebral,Strokes, Cerebrovascular,Vascular Accidents, Brain

Related Publications

M Hidalgo de la Cruz, and J A Miranda Acuña, and E Luque Buzo, and B Chavarria Cano, and E Esteban de Antonio, and J Prieto Montalvo, and M L Galiano Fragua, and A Massot-Tarrús
January 2023, Therapeutic advances in neurological disorders,
M Hidalgo de la Cruz, and J A Miranda Acuña, and E Luque Buzo, and B Chavarria Cano, and E Esteban de Antonio, and J Prieto Montalvo, and M L Galiano Fragua, and A Massot-Tarrús
September 2022, Neurology,
M Hidalgo de la Cruz, and J A Miranda Acuña, and E Luque Buzo, and B Chavarria Cano, and E Esteban de Antonio, and J Prieto Montalvo, and M L Galiano Fragua, and A Massot-Tarrús
January 2000, Epilepsia,
M Hidalgo de la Cruz, and J A Miranda Acuña, and E Luque Buzo, and B Chavarria Cano, and E Esteban de Antonio, and J Prieto Montalvo, and M L Galiano Fragua, and A Massot-Tarrús
June 2015, Journal of epilepsy research,
M Hidalgo de la Cruz, and J A Miranda Acuña, and E Luque Buzo, and B Chavarria Cano, and E Esteban de Antonio, and J Prieto Montalvo, and M L Galiano Fragua, and A Massot-Tarrús
October 2013, The Journal of pediatrics,
M Hidalgo de la Cruz, and J A Miranda Acuña, and E Luque Buzo, and B Chavarria Cano, and E Esteban de Antonio, and J Prieto Montalvo, and M L Galiano Fragua, and A Massot-Tarrús
November 2021, Healthcare (Basel, Switzerland),
M Hidalgo de la Cruz, and J A Miranda Acuña, and E Luque Buzo, and B Chavarria Cano, and E Esteban de Antonio, and J Prieto Montalvo, and M L Galiano Fragua, and A Massot-Tarrús
February 2020, Acta neurologica Scandinavica,
M Hidalgo de la Cruz, and J A Miranda Acuña, and E Luque Buzo, and B Chavarria Cano, and E Esteban de Antonio, and J Prieto Montalvo, and M L Galiano Fragua, and A Massot-Tarrús
September 2003, Seizure,
M Hidalgo de la Cruz, and J A Miranda Acuña, and E Luque Buzo, and B Chavarria Cano, and E Esteban de Antonio, and J Prieto Montalvo, and M L Galiano Fragua, and A Massot-Tarrús
January 2019, Iranian journal of child neurology,
M Hidalgo de la Cruz, and J A Miranda Acuña, and E Luque Buzo, and B Chavarria Cano, and E Esteban de Antonio, and J Prieto Montalvo, and M L Galiano Fragua, and A Massot-Tarrús
December 2014, Seminars in pediatric neurology,
Copied contents to your clipboard!